Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer
ConclusionsOur retrospective analyses suggest that long-term statin use (> 5 years) was associated with improved OS and DFS in women with breast cancer regardless of receptor subtype, even after adjusting for metabolic comorbidities.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cholesterol | Statin Therapy | Statistics | Students | Study | Universities & Medical Training | Women